Last reviewed · How we verify
Tang-min Lin pill
Tang-min Lin pill's mechanism is not well-documented.
Tang-min Lin pill's mechanism is not well-documented. Used for Atrial fibrillation for stroke prevention.
At a glance
| Generic name | Tang-min Lin pill |
|---|---|
| Sponsor | Guang'anmen Hospital of China Academy of Chinese Medical Sciences |
| Modality | Small molecule |
| Phase | Phase 3 |
Mechanism of action
Unfortunately, there is limited information available on the exact mechanism of action of Tang-min Lin pill.
Approved indications
- Atrial fibrillation for stroke prevention
Common side effects
- Nausea
- Headache
- Dizziness
Key clinical trials
- Trial of Tang-min-ling Pills in the Treatment of Type 2 Diabetes (PHASE2)
- Clinical Trail of Tang-min-Ling Pills in Type 2 Diabetes Mellitus (PHASE3)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape: